Intellectus Partners’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.1M | Hold |
2,715
| – | – | 0.43% | 64 |
|
|
2025
Q4 | $2.1M | Sell |
2,715
-28
| -1% | -$19K | 0.41% | 64 |
|
|
2025
Q3 | $1.54M | Buy |
2,743
+93
| +4% | +$52.6K | 0.3% | 90 |
|
|
2025
Q2 | $1.39M | Buy |
2,650
+617
| +30% | +$344K | 0.3% | 94 |
|
|
2025
Q1 | $1.29M | Buy |
2,033
+978
| +93% | +$673K | 0.32% | 93 |
|
|
2024
Q4 | $752K | Hold |
1,055
| – | – | 0.17% | 158 |
|
|
2024
Q3 | $1.11M | Hold |
1,055
| – | – | 0.28% | 105 |
|
|
2024
Q2 | $1.11M | Sell |
1,055
-100
| -9% | -$96.9K | 0.3% | 90 |
|
|
2024
Q1 | $1.11M | Sell |
1,155
-125
| -10% | -$119K | 0.29% | 101 |
|
|
2023
Q4 | $1.12M | Hold |
1,280
| – | – | 0.32% | 85 |
|
|
2023
Q3 | $1.05M | Sell |
1,280
-397
| -24% | -$312K | 0.33% | 87 |
|
|
2023
Q2 | $1.2M | Sell |
1,677
-200
| -11% | -$154K | 0.36% | 79 |
|
|
2023
Q1 | $1.54M | Buy |
1,877
+22
| +1% | +$16.6K | 0.49% | 60 |
|
|
2022
Q4 | $1.34M | Sell |
1,855
-42
| -2% | -$31K | 0.47% | 60 |
|
|
2022
Q3 | $1.31M | Sell |
1,897
-88
| -4% | -$55.4K | 0.46% | 60 |
|
|
2022
Q2 | $1.17M | Hold |
1,985
| – | – | 0.4% | 72 |
|
|
2022
Q1 | $1.39M | Sell |
1,985
-175
| -8% | -$111K | 0.41% | 64 |
|
|
2021
Q4 | $1.36M | Sell |
2,160
-550
| -20% | -$338K | 0.35% | 76 |
|
|
2021
Q3 | $1.64M | Buy |
2,710
+215
| +9% | +$133K | 0.4% | 66 |
|
|
2021
Q2 | $1.39M | Buy |
2,495
+30
| +1% | +$15.2K | 0.31% | 81 |
|
|
2021
Q1 | $1.17M | Sell |
2,465
-815
| -25% | -$397K | 0.32% | 90 |
|
|
2020
Q4 | $1.58M | Buy |
3,280
+1,028
| +46% | +$555K | 0.47% | 61 |
|
|
2020
Q3 | $1.26M | Buy |
2,252
+778
| +53% | +$472K | 0.48% | 56 |
|
|
2020
Q2 | $919K | Buy |
1,474
+41
| +3% | +$23.3K | 0.36% | 81 |
|
|
2020
Q1 | $700K | Sell |
1,433
-3,245
| -69% | -$1.34M | 0.33% | 88 |
|
|
2019
Q4 | $1.76M | Buy |
4,678
+947
| +25% | +$319K | 0.71% | 36 |
|
|
2019
Q3 | $1.03M | Buy |
3,731
+933
| +33% | +$276K | 0.45% | 59 |
|
|
2019
Q2 | $876K | Buy |
2,798
+462
| +20% | +$154K | 0.38% | 79 |
|
|
2019
Q1 | $959K | Sell |
2,336
-141
| -6% | -$58.1K | 0.41% | 68 |
|
|
2018
Q4 | $925K | Buy |
2,477
+1,128
| +84% | +$413K | 0.63% | 41 |
|
|
2018
Q3 | $545K | Sell |
1,349
-895
| -40% | -$341K | 0.19% | 135 |
|
|
2018
Q2 | $774K | Buy |
2,244
+929
| +71% | +$291K | 0.28% | 101 |
|
|
2018
Q1 | $453K | Sell |
1,315
-108
| -8% | -$37.6K | 0.16% | 147 |
|
|
2017
Q4 | $535K | Hold |
1,423
| – | – | 0.2% | 127 |
|
|
2017
Q3 | $636K | Sell |
1,423
-326
| -19% | -$155K | 0.26% | 93 |
|
|
2017
Q2 | $859K | Buy |
1,749
+93
| +6% | +$40.7K | 0.39% | 67 |
|
|
2017
Q1 | $642K | Buy |
1,656
+29
| +2% | +$10.7K | 0.33% | 82 |
|
|
2016
Q4 | $597K | Buy |
+1,627
| New | +$619K | 0.31% | 87 |
|
Other funds holding REGN
VCM
N